Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of DirectorsBusiness Wire • 8 days ago
Vir Biotechnology, Inc. (Vir or the Company, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (the Board) at its upcoming...
Share to Feed
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31, 2024, on May 2, 2024. The Company...
Related Stocks: VIR...
Vir Biotechnology, Inc. (NASDAQ:VIR Get Free Report) CFO Sung Lee sold 6,008 shares of Vir Biotechnology stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at...
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results PR Newswire DURHAM...
Investors considering a purchase of Vir Biotechnology Inc (VIR) shares, but cautious about paying the going market price of 10.69/share, might benefit from considering selling puts among the...
This indicator may be signaling that VIR's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that its Phase 2 SOLSTICE clinical trial evaluating the safety, tolerability and efficacy of tobevibart and elebsiran for the treatment of people...
Vir Biotechnology (NASDAQ:VIR Get Free Report) and Compugen (NASDAQ:CGEN Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the...
Vir Biotechnology, Inc. (NASDAQ:VIR Get Free Report)s share price fell 2.7% during mid-day trading on Tuesday following insider selling activity. The stock traded as low as $11.42 and...